These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

834 related articles for article (PubMed ID: 37191444)

  • 41. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diet-Host-Microbiota Interactions Shape Aryl Hydrocarbon Receptor Ligand Production to Modulate Intestinal Homeostasis.
    Han H; Safe S; Jayaraman A; Chapkin RS
    Annu Rev Nutr; 2021 Oct; 41():455-478. PubMed ID: 34633858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.
    Lamas B; Richard ML; Leducq V; Pham HP; Michel ML; Da Costa G; Bridonneau C; Jegou S; Hoffmann TW; Natividad JM; Brot L; Taleb S; Couturier-Maillard A; Nion-Larmurier I; Merabtene F; Seksik P; Bourrier A; Cosnes J; Ryffel B; Beaugerie L; Launay JM; Langella P; Xavier RJ; Sokol H
    Nat Med; 2016 Jun; 22(6):598-605. PubMed ID: 27158904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.
    Iyer N; Corr SC
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.
    Lamas B; Martins Breyner N; Houdeau E
    Part Fibre Toxicol; 2020 Jun; 17(1):19. PubMed ID: 32487227
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
    Gonçalves P; Araújo JR; Di Santo JP
    Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Caspase recruitment domain 9, microbiota, and tryptophan metabolism: dangerous liaisons in inflammatory bowel diseases.
    Lamas B; Richard ML; Sokol H
    Curr Opin Clin Nutr Metab Care; 2017 Jul; 20(4):243-247. PubMed ID: 28399013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Host-microbiota interaction in intestinal stem cell homeostasis.
    Wu H; Mu C; Xu L; Yu K; Shen L; Zhu W
    Gut Microbes; 2024; 16(1):2353399. PubMed ID: 38757687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spontaneous episodic inflammation in the intestines of mice lacking HNF4A is driven by microbiota and associated with early life microbiota alterations.
    Kelly C; Jawahar J; Davey L; Everitt JI; Galanko JA; Anderson C; Avendano JE; McCann JR; Sartor RB; Valdivia RH; Rawls JF
    mBio; 2023 Aug; 14(4):e0150423. PubMed ID: 37526424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fine-tuning of the mucosal barrier and metabolic systems using the diet-microbial metabolite axis.
    Nagai M; Obata Y; Takahashi D; Hase K
    Int Immunopharmacol; 2016 Aug; 37():79-86. PubMed ID: 27133028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction between the gut microbiome and mucosal immune system.
    Shi N; Li N; Duan X; Niu H
    Mil Med Res; 2017; 4():14. PubMed ID: 28465831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting the aryl hydrocarbon receptor by gut phenolic metabolites: A strategy towards gut inflammation.
    Pinto CJG; Ávila-Gálvez MÁ; Lian Y; Moura-Alves P; Nunes Dos Santos C
    Redox Biol; 2023 May; 61():102622. PubMed ID: 36812782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Host-microbiota interactions in inflammatory bowel disease.
    Caruso R; Lo BC; Núñez G
    Nat Rev Immunol; 2020 Jul; 20(7):411-426. PubMed ID: 32005980
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysbiotic events in gut microbiota: impact on human health.
    Schippa S; Conte MP
    Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System.
    Yue B; Luo X; Yu Z; Mani S; Wang Z; Dou W
    Microorganisms; 2019 Oct; 7(10):. PubMed ID: 31614539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
    Peng K; Xia S; Xiao S; Yu Q
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roles of intestinal epithelial cells in the maintenance of gut homeostasis.
    Okumura R; Takeda K
    Exp Mol Med; 2017 May; 49(5):e338. PubMed ID: 28546564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.